Panitumumab in Children With Solid Tumors
NCT00658658
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
BIOLOGICAL:
Panitumumab
Sponsor
Amgen